Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 5Active not recruiting 3Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13Gastrointestinal 9Thoracic 7Other hematologic neoplasm 6Genitourinary 5Tumor-Agnostic 3Gynecologic 3Sarcoma 2Plasma cell 2Other solid neoplasm 2Myeloid 2Head & Neck 2Dermatologic 2Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Lymphoma, Mantle-Cell 1

Interventions

Rituximab 702Cyclophosphamide 643Vincristine 352Doxorubicin 307Etoposide 303Cytarabine 270Filgrastim 250Prednisone 248Methotrexate 240fludarabine phosphate 231Dexamethasone 208fludarabine 183Peripheral Blood Stem Cell Transplantation 165Radiotherapy 160Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 110Mycophenolic Acid 107Whole-Body Irradiation 106Tacrolimus 96Cyclosporine 86Gemcitabine 82Ifosfamide 80Alemtuzumab 80Calcium Dobesilate 79Leucovorin 77

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Practice Guidelines as Topic × Lymphoid × Clear all
NCT03219047 2023-07-27

Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
1 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡